BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6200212)

  • 1. Characterization of the association of radiolabeled bleomycin A2 with HeLa cells.
    Roy SN; Horwitz SB
    Cancer Res; 1984 Apr; 44(4):1541-6. PubMed ID: 6200212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical synthesis of radiolabeled bleomycin A2 and its binding to DNA.
    Roy SN; Orr GA; Brewer CF; Horwitz SB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4471-7. PubMed ID: 6171340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of the initial reaction of bleomycin and several of its metal complexes with Ehrlich cells.
    Lyman S; Ujjani B; Renner K; Antholine W; Petering DH; Whetstone JW; Knight JM
    Cancer Res; 1986 Sep; 46(9):4472-8. PubMed ID: 2425953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary fate of [3H]bleomycin A2 in mice.
    Lazo JS; Pham ET
    J Pharmacol Exp Ther; 1984 Jan; 228(1):13-8. PubMed ID: 6198509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon inhibition of thymidine incorporation into DNA through effects on thymidine transport and uptake.
    Pfeffer LM; Tamm I
    J Cell Physiol; 1984 Nov; 121(2):431-6. PubMed ID: 6490733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid alters subcellular compartmentalization of ATP pools in 3T3 cells but not in HeLa cells.
    Schroder EW; Rapaport E
    J Cell Physiol; 1984 Aug; 120(2):204-10. PubMed ID: 6204999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of bleomycin to DNA in bleomycin-sensitive and -resistant rat ascites hepatoma cells.
    Miyaki M; Ono T; Hori S; Umezawa H
    Cancer Res; 1975 Aug; 35(8):2015-19. PubMed ID: 50129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic approach toward the analysis of drug-DNA interactions using Raman spectroscopy: the binding of metal-free bleomycins A(2) and B(2) to calf thymus DNA.
    Rajani C; Kincaid JR; Petering DH
    Biopolymers; 1999; 52(3):110-28. PubMed ID: 11169380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of basic fibroblast growth factor (FGF-2) with nonresponsive HeLa cells.
    Gannoun-Zaki L; Pieri I; Badet J; Barritault D
    Exp Cell Res; 1994 Aug; 213(2):375-82. PubMed ID: 8050494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a plasma membrane protein that specifically binds bleomycin.
    Pron G; Belehradek J; Mir LM
    Biochem Biophys Res Commun; 1993 Jul; 194(1):333-7. PubMed ID: 7687434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal effect of bleomycin and peplomycin on HeLa cells in multicell tumor spheroids.
    Sasaki T; Yamamoto M; Kuwahara K
    Cancer Res; 1984 Apr; 44(4):1374-9. PubMed ID: 6200210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [3H]SR 48692, the first nonpeptide neurotensin antagonist radioligand: characterization of binding properties and evidence for distinct agonist and antagonist binding domains on the rat neurotensin receptor.
    Labbé-Jullié C; Botto JM; Mas MV; Chabry J; Mazella J; Vincent JP; Gully D; Maffrand JP; Kitabgi P
    Mol Pharmacol; 1995 May; 47(5):1050-6. PubMed ID: 7746272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origin and cytotoxic properties of base propenals derived from DNA.
    Grollman AP; Takeshita M; Pillai KM; Johnson F
    Cancer Res; 1985 Mar; 45(3):1127-31. PubMed ID: 2578872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
    Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
    J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of specific binding of [3H]phorbol 12,13-dibutyrate and [3H]phorbol 12-myristate 13-acetate to mouse brain.
    Dunphy WG; Delclos KB; Blumberg PM
    Cancer Res; 1980 Oct; 40(10):3635-41. PubMed ID: 7438048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal binding to modified bleomycins. Zinc and ferrous complexes with an acetylated bleomycin.
    Oppenheimer NJ; Rodriguez LO; Hecht SM
    Biochemistry; 1980 Aug; 19(17):4096-103. PubMed ID: 6157406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper(II).bleomycin, iron(III).bleomycin, and copper(II).phleomycin: comparative study of deoxyribonucleic acid binding.
    Povirk LF; Hogan M; Dattagupta N; Buechner M
    Biochemistry; 1981 Feb; 20(3):665-71. PubMed ID: 6163448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and uptake characteristics of human cell variants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone).
    Wiseman A; Kramer DL; Porter CW
    Cancer Res; 1983 Dec; 43(12 Pt 1):5937-42. PubMed ID: 6315222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of serotonin uptake in cultured pheochromocytoma cells. Comparison with norepinephrine uptake.
    Yoffe JR; Borchardt RT
    Mol Pharmacol; 1982 Mar; 21(2):368-73. PubMed ID: 7099140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.